Characterization of the role of etallothionein-3 in an animal model of Alzheimer's disease

Cellular and Molecular Life Sciences

Volumn 69, Issue 21, 2012, Pages 3683-3700

  Manso, Yasmina ^a   Carrasco, Javier ^a   Comes, Gemma ^a   Meloni, Gabriele ^b,c   Adlard, Paul A ^d   Bush, Ashley I ^d   Vašák, Milan ^b   Hidalgo, Juan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c California Institute of Technology   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyloid plaques; Behavior; Body weight; Gliosis; Metallothionein; Metals; Survival; Tg2576

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; METALLOTHIONEIN III; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); GROWTH INHIBITOR; NERVE PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; EXPLORATORY BEHAVIOR; FEMALE; GENDER; GLIOSIS; HIPPOCAMPUS; LOCOMOTION; MALE; MAZE TEST; MORTALITY; MOUSE; MUTATION; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SWEDISH MUTATION; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS;

EID: 84867849376     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1047-9     Document Type: Article

References (105)

1. Adlard PA, Bush AI (2006) Metals and Alzheimer's disease. J Alzheimers Dis 10:145-163
2. Amoureux MC, Van Gool D, Herrero MT, Dom R, Colpaert FC, Pauwels PJ (1997) Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired. Mol Chem Neuropathol 32:101-121
3. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53:1992-1997
4. Angeletti B, Waldron KJ, Freeman KB, Bawagan H, Hussain I, Miller CC, Lau KF, Tennant ME, Dennison C, Robinson NJ, Dingwall C (2005) BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J Biol Chem 280:17930-17937
5. Arendash GW, Gordon MN, Diamond DM, Austin LA, Hatcher JM, Jantzen P, DiCarlo G, Wilcock D, Morgan D (2001) Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol 20:737-744
6. Aschner M (1997) Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann N Y Acad Sci 825:334-347
7. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, BennettDA(2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685-691
8. Bayer TA, Scha;fer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schu;ssel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100:14187-14192
9. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101:2173- 2178
10. Borg J, Chereul E (2008) Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD. J Neurosci Res 86:3275-3284
11. Bruinink A, Faller P, Sidler C, Bogumil R, Vasa'k M (1998) Growth inhibitory factor and zinc affect neural cell cultures in a tissue specific manner. Chem Biol Interact 115:167-174
12. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5:421-432
13. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC (2001) Augmented senile plaque load in aged female betaamyloid precursor protein-transgenic mice. Am J Pathol 158:1173-1177
14. Carlson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK (1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 6:1951-1959
15. Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J (2006) Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 143:911-922
16. Carrasco J, Giralt M, Molinero A, Penkowa M, Moos T, Hidalgo J (1999) Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I ? II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains. J Neurotrauma 16:1115-1129
17. Carrasco J, Penkowa M, Giralt M, Camats J, Molinero A, Campbell IL, Palmiter RD, Hidalgo J (2003) Role of metallothionein- III following central nervous system damage. Neurobiol Dis 13:22-36
18. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer- like neuropathology in female 3xTg-AD mice. J Neurosci 27:13357-13365
19. Ceballos D, Lago N, Verdu E, Penkowa M, Carrasco J, Navarro X, Palmiter RD, Hidalgo J (2003) Role of metallothioneins in peripheral nerve function and regeneration. Cell Mol Life Sci 60:1209-1216
20. Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, McGaugh JL, LaFerla FM (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 28:76-82
21. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and proinflammatory signaling. J Neurosci Res 70:462-473
22. Cole TB, Robbins CA, Wenzel HJ, Schwartzkroin PA, Palmiter RD (2000) Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39:153-169
23. Cyr DG, Dufresne J, Pillet S, Alfieri TJ, Hermo L (2001) Expression and regulation of metallothioneins in the rat epididymis. J Androl 22:124-135
24. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2:271-276
25. Chung RS, Howells C, Eaton ED, Shabala L, Zovo K, Palumaa P, Sillard R, Woodhouse A, Bennett WR, Ray S, Vickers JC, West AK (2010) The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons. PLoS ONE 5:e12030
26. Chung RS, Vickers JC, Chuah MI, Eckhardt BL, West AK (2002) Metallothionein-III inhibits initial neurite formation in developing neurons as well as postinjury, regenerative neurite sprouting. Exp Neurol 178:1-12
27. De Strooper B (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 90:465-494
28. Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA (2006) Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20:426-433
29. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR (2003) Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42:2768-2773
30. Durand J, Meloni G, Talmard C, Vasa'k M, Faller P (2010) Zinc release of Zn7-metallothionein-3 induces fibrillar type amyloidb aggregates. Metallomics 2:741-744
31. El Ghazi I, Martin BL, Armitage IM (2006) Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp Biol Med (Maywood) 231:1500-1506
32. El Ghazi I, Martin BL, Armitage IM (2010) New proteins found interacting with brain metallothionein-3 are linked to secretion. Int J Alzheimers Dis 2011:208634
33. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432-438
34. Erickson JC, Hollopeter G, Thomas SA, Froelick GJ, Palmiter RD (1997) Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 17:1271-1281
35. Erickson JC, Masters BA, Kelly EJ, Brinster RL, Palmiter RD (1995) Expression of human metallothionein-III in transgenic mice. Neurochem Int 27:35-41
36. Erickson JC, Sewell AK, Jensen LT, Winge DR, Palmiter RD (1994) Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein- III (GIF). Brain Res 649:297-304
37. Faller P, Hasler DW, Zerbe O, Klauser S, Winge DR, Vasa'k M (1999) Evidence for a dynamic structure of human neuronal growth inhibitory factor and for major rearrangements of its metal- thiolate clusters. Biochemistry 38:10158-10167
38. Fernandes C, Gonza'lez MI, Wilson CA, File SE (1999) Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety. Pharmacol Biochem Behav 64:731-738
39. Gitter BD, Regoli D, Howbert JJ, Glasebrook AL, Waters DC (1994) Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol 51:101-108
40. Guglielmotto M, Giliberto L, Tamagno E, Tabaton M (2010) Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Front Aging Neurosci 2:3
41. Hasler DW, Jensen LT, Zerbe O, Winge DR, Vasa'k M (2000) Effect of the two conserved prolines of human growth inhibitory factor (metallothionein-3) on its biological activity and structure fluctuation: comparison with a mutant protein. Biochemistry 39:14567-14575
42. Heneka MT, O'Banion MK, Terwel D, Kummer MP (2010) Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117:919-947
43. Hidalgo J, Penkowa M, Espejo C, Marti Nez-Ca Ceres EM, Carrasco J, Quintana A, Molinero A, Florit S, Giralt M, Ortega- Aznar A (2006) Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med (Maywood) 231:1450-1458
44. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100
45. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29:177-185
46. Hozumi I, Uchida Y, Watabe K, Sakamoto T, Inuzuka T (2006) Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci Lett 395:220-223
47. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102
48. Hua H, Mu;nter L, Harmeier A, Georgiev O, Multhaup G, Schaffner W (2011) Toxicity of Alzheimer's disease-associated Ab peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Biol Chem 392:919-926
49. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2:157-161
50. Iguchi K, Morihara N, Usui S, Hayama M, Sugimura Y, Hirano K (2011) Castration- and aging-induced changes in the expression of zinc transporter and metallothionein in rat prostate. J Androl 32:144-150
51. Irie Y, Keung WM (2001) Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides. Biochem Biophys Res Commun 282:416-420
52. Irie Y, Keung WM (2003) Anti-amyloid beta activity of metallothionein-III is different from its neuronal growth inhibitory activity: structure-activity studies. Brain Res 960:228-234
53. Ittner LM, Go;tz J (2011) Amyloid-b and tau - a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12:65-72
54. King DL, Arendash GW (2002) Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 75:627-642
55. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 103:145-162
56. Knipp M, Meloni G, Roschitzki B, Vasa'k M (2005) Zn7metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry 44:3159-3165
57. Koumura A, Kakefuda K, Honda A, Ito Y, Tsuruma K, Shimazawa M, Uchida Y, Hozumi I, Satoh M, Inuzuka T, Hara H (2009) Metallothionein-3 deficient mice exhibit abnormalities of psychological behaviors. Neurosci Lett 467:11-14
58. Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J, Duff K, Dickson D, Van Broeckhoven C (2005) Densecore plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol 167:527-543
59. Lahti DW, Hoekman JD, Tokheim AM, Martin BL, Armitage IM (2005) Identification of mouse brain proteins associated with isoform 3 of metallothionein. Protein Sci 14:1151-1157
60. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C (2002) Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 956:36-44
61. Lalonde R, Lewis TL, Strazielle C, Kim H, Fukuchi K (2003) Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res 977:38-45
62. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99:7705-7710
63. Lee JY, Mook-Jung I, Koh JY (1999) Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice. J Neurosci 19:RC10:1-5
64. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352-357
65. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics 33:240-256
66. Manso Y, Adlard PA, Carrasco J, Vasa'k M, Hidalgo J (2011) Metallothionein and brain inflammation. J Biol Inorg Chem 16:1103-1113
67. Massaad CA, Washington TM, Pautler RG, Klann E (2009) Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106:13576-13581
68. Masters BA, Quaife CJ, Erickson JC, Kelly EJ, Froelick GJ, Zambrowicz BP, Brinster RL, Palmiter RD (1994) Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 14:5844-5857
69. Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, Bush AI (2006) Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J Inorg Biochem 100:952-962
70. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the agedependent elevations of brain copper and iron. J Biol Chem 277:44670-44676
71. Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce- Levie K, Cheng IH, Yu GQ, Mucke L (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci Res 29:1977-1986
72. Meloni G, Knipp M, Vasa'k M (2005) Detection of neuronal growth inhibitory factor (metallothionein-3) in polyacrylamide gels and by Western blot analysis. J Biochem Biophys Methods 64:76-81
73. Meloni G, Sonois V, Delaine T, Guilloreau L, Gillet A, Teissié J, Faller P, Vasa'k M (2008) Metal swap between Zn7-metallothionein- 3 and amyloid-beta-Cu protects against amyloid-beta toxicity. Nat Chem Biol 4:366-372
74. Meloni G, Vasa'k M (2011) Redox activity of a-synuclein-Cu is silenced by Zn7-metallothionein-3. Free Radic Biol Med 50:1471-1479
75. Moffatt P, Se'guin C (1998) Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol 17:501-510
76. Montoliu C, Monfort P, Carrasco J, Palacios O, Capdevila M, Hidalgo J, Felipo V (2000) Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J Neurochem 75:266-273
77. Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311-10324
78. Palumaa P, Tammiste I, Kruusel K, Kangur L, Jornvall H, Sillard R (2005) Metal binding of metallothionein-3 versus metallothionein-2: lower affinity and higher plasticity. Biochim Biophys Acta 1747:205-211
79. Pedersen AO, Jacobsen J (1980) Reactivity of the thiol group in human and bovine albumin at pH 3-9, as measured by exchange with 2,20-dithiodipyridine. Eur J Biochem 106:291-295
80. Pedersen JT, Hureau C, Hemmingsen L, Heegaard NH, Ostergaard J, VasákM, Faller P (2012) Rapid exchange of metal between Zn(7)-metallothionein-3 and amyloid-b peptide promotes amyloid- related structural changes. Biochem 51:1697-1706
81. Penkowa M, Tió L, Giralt M, Quintana A, Molinero A, Atrian S, Vasa'k M, Hidalgo J (2006) Specificity and divergence in the neurobiological effects of different metallothioneins after brain injury. J Neurosci Res 83:974-984
82. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci USA 100:14193-14198
83. Pirev E, Ince Y, Sies H, Kro;ncke KD (2010) Heat shock but not cold shock leads to disturbed intracellular zinc homeostasis. J Cell Physiol 223:103-109
84. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D (2007) Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178:18-28
85. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL (2002) Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 22:8790-8796
86. Romero-Isart N, Jensen LT, Zerbe O, Winge DR, Vasa'k M (2002) Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1. J Biol Chem 277:37023-37028
87. Rosario ER, Carroll J, Pike CJ (2010) Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res 1359:281-290
88. Scha;fer S, Pajonk FG, Multhaup G, Bayer TA (2007) Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. J Mol Med (Berl) 85:405-413
89. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR (1995) Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 34:4740-4747
90. Sinforiani E, Citterio A, Zucchella C, Bono G, Corbetta S, Merlo P, Mauri M (2010) Impact of gender differences on the outcome of Alzheimer's disease. Dement Geriatr Cogn Disord 30:147-154
91. Suh SW, Jensen KB, Jensen MS, Silva DS, Kesslak PJ, Danscher G, Frederickson CJ (2000) Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res 852:274-278
92. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19:341-353
93. Toda T, Noda Y, Ito G, Maeda M, Shimizu T (2011) Presenilin- 2 mutation causes early amyloid accumulation and memory impairment in a transgenic mouse model of Alzheimer's disease. J Biomed Biotechnol 2011:617974
94. Tougu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, Palumaa P (2009) Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J Neurochem 110:1784-1795
95. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T (1992) Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J 11:4843-4850
96. Twine NA, Janitz K, Wilkins MR, Janitz M (2011) Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS ONE 6:e16266
97. Uchida Y, Gomi F, Masumizu T, Miura Y (2002) Growth inhibitory factor prevents neurite extension and death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem 277:32353-32359
98. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M (1991) The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337-347
99. VasákM(1991) Metal removal and substitution in vertebrate and invertebrate metallothioneins. Methods Enzymol, 205:452-458
100. Vasa'k M, Meloni G (2011) Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 16:1067-1078
101. Vest RS, Pike CJ (2012) Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav (in press). doi:10.1016/ j.yhbeh.2012.04.006
102. Wang G, Zhang Y, Chen B, Cheng J (2003) Preliminary studies on Alzheimer's disease using cDNA microarrays. Mech Ageing Dev 124:115-124
103. West AK, Hidalgo J, Eddins D, Levin ED, Aschner M (2008) Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology 29:489-503
104. West AK, Leung JY, Chung RS (2011) Neuroprotection and regeneration by extracellular metallothionein via lipoproteinreceptor- related proteins. J Biol Inorg Chem, 16:1115-1122
105. Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE (2001) Metallothionein III is reduced in Alzheimer's disease. Brain Res 894:37-45